30 results on '"Puzio-Kuter, Anna"'
Search Results
2. Data from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
3. Data from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
4. Perspective on this Article from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
5. Perspective on this Article from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
6. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
7. Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
8. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
9. Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
10. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
11. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
12. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
13. Supplementary Data from ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
14. Abstract 1295: Small molecule reactivators of Y220C mutant p53 modulate tumor infiltrating leukocytes and synergize with immune checkpoint inhibitors
15. Abstract LB006: PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development
16. ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
17. The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation
18. Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
19. DTIE, a novel core promoter element that directs start site selection in TATA-less genes
20. The Evolution of Tumors in Mice and Humans with Germline p53 Mutations
21. Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li–Fraumeni cancer predisposition syndrome
22. The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway
23. 367 NOVEL P53-INDEPENDENT FUNCTIONS OF ARF IN THE CONTEXT OF COMBINED FUNCTINAL LOSS OF P53 AND PTEN IN A MOUSE MODEL OF INVASIVE BLADDER CANCER
24. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
25. Mouse Models of Human Bladder Cancer as a Tool for Drug Discovery
26. Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
27. Stem cell biology meets p53
28. COMBINATORIAL P53 AND PTEN INACTIVATION PROMOTES INVASIVE BLADDER CANCER
29. Inactivation of p53 and Pten promotes invasive bladder cancer
30. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.